SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Rachel Carson Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientRachel Carson
Date of birth1907-05-27
IdentifiersMRN HR-ML041-SYN-TD; SSN (made up) 000-41-5068
Document date2026-11-01
AuthorMargaret Vance-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit for a new left breast lump; follow-up of a recently treated duodenal ulcer. Concerns: A firm lump in the left breast she found two weeks ago; Wants to be told plainly and in person what any test shows, to see the reports herself, and to make her own decisions; asks that her health be shared only with the people she chooses; Worried that illness will keep her from finishing her book. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth once daily before breakfast, to complete eight weeks of ulcer healingOne capsule once daily before breakfastOral route1960-01-19 to 1960-04-03completedS
Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for knee pain, no more than 3000 mg a dayTwo tablets up to every 8 hours as neededOral route1959-06-02activeS
Letrozole 2.5 mg oral tablet, one tablet by mouth once daily, planned for at least five yearsOne tablet once dailyOral route1960-06-15activeS
Ribociclib 200 mg oral tablet, two tablets (400 mg) by mouth once daily on days 1 to 21 of each 28-day cycle, with letrozole, planned for three yearsTwo tablets once daily on days 1 to 21 of each 28-day cycleOral route1960-06-15activeS
Zoledronic acid 4 mg in 100 mL intravenous infusion over 15 minutes every six months for three yearsOne infusion every six monthsIntravenous route1960-06-15activeS
Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once dailyOne tablet once dailyOral route1960-06-15activeS

Procedures

ProcedureDatesStatusEvidence
Diagnostic mammography of the left breast with a right breast view: 2.4 cm irregular spiculated mass at 2 o'clock in the upper outer left breast; scattered fibroglandular density; right breast normal; BI-RADS 51960-03-11 to 1960-03-11completedS
Left breast and axillary ultrasound: 2.4 cm irregular hypoechoic mass at 2 o'clock, 7 cm from the nipple; axillary lymph nodes normal in size and shape1960-03-11 to 1960-03-11completedS
Ultrasound-guided core needle biopsy of the left breast mass with clip placement: invasive ductal carcinoma, grade 2; ER 95 percent, PR 80 percent, HER2 1+ (negative), Ki-67 22 percent1960-03-13 to 1960-03-13completedS
Genetic counseling and germline multigene panel testing for inherited breast cancer risk: no pathogenic variant1960-03-18 to 1960-03-18completedS
Left breast lumpectomy (breast-conserving surgery) with wire-free localization of the biopsy clip, her informed choice. Pathology: invasive ductal carcinoma 2.3 cm, grade 2, margins clear (closest 4 mm), no lymphovascular invasion; pT2. Recurrence score (21-gene assay) 171960-04-06 to 1960-04-06completedS
Left axillary sentinel lymph node biopsy at lumpectomy: 2 of 3 nodes with macrometastases (largest 6 mm), no extranodal extension; pN1a(sn)1960-04-06 to 1960-04-06completedS
13C urea breath test four weeks after bismuth quadruple therapy and two weeks after stopping omeprazole: negative; Helicobacter pylori eradicated1960-04-17 to 1960-04-17completedS
Hypofractionated radiation to the left whole breast and regional lymph nodes, 40 Gy in 15 fractions, with a tumor-bed boost of 10 Gy in 4 fractions; completed with grade 1 skin reddening1960-05-04 to 1960-05-29completedS
Baseline bone density scan (DXA) before letrozole: lumbar spine T-score -1.8, femoral neck T-score -1.3 (low bone mass)1960-06-15 to 1960-06-15completedS
Baseline 12-lead electrocardiogram before ribociclib: sinus rhythm 70/min, QTcF 418 ms1960-06-15 to 1960-06-15completedS

Immunizations

DateVaccineStatusEvidence
1959-10-14Influenza vaccine, 1959-1960 seasoncompletedS
1955-05-10Tdap vaccinecompletedS
1960-10-13Influenza vaccine, 1960-1961 seasoncompletedS
1960-10-13Pneumococcal conjugate vaccine PCV20completedS
1960-10-13Recombinant zoster vaccine, dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1950Benign tumor removed from the left breastD (CLM-0004)
Early 1960Two lumps found in the left breast while writing a bookD (CLM-0006)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
A firm lump in the left breast she found two weeks agoactiveS
Wants to be told plainly and in person what any test shows, to see the reports herself, and to make her own decisions; asks that her health be shared only with the people she choosesactiveS
Worried that illness will keep her from finishing her bookactiveS

Assessment

Most recent measures: Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1960-10-13; Hemoglobin [Mass/volume] in Blood 12.2 on 1960-07-20; Leukocytes [#/volume] in Blood by Automated count 2.9 on 1960-07-20; Platelets [#/volume] in Blood by Automated count 168 on 1960-07-20; Creatinine [Mass/volume] in Serum or Plasma 0.8 on 1960-09-08; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 on 1960-09-08; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 29 on 1960-09-08; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1960-09-08; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 5 on 1960-04-20; Neutrophils [#/volume] in Blood by Automated count 1.2 on 1960-07-20; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1955)/1.73 sq M 87 on 1960-06-15; Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 on 1960-09-08; Potassium [Moles/volume] in Serum or Plasma 4.1 on 1960-09-08; Magnesium [Mass/volume] in Serum or Plasma 2 on 1960-09-08; Calcium [Mass/volume] in Serum or Plasma 9.5 on 1960-09-08; Cholesterol [Mass/volume] in Serum or Plasma 208 on 1960-06-15; Cholesterol in HDL [Mass/volume] in Serum or Plasma 62 on 1960-06-15; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 124 on 1960-06-15; Triglyceride [Mass/volume] in Serum or Plasma 110 on 1960-06-15; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 34 on 1960-09-08; Q-T interval corrected 418 on 1960-06-15; DXA Lumbar spine [T-score] Bone density -1.8 on 1960-06-15; DXA Femur [T-score] Bone density -1.3 on 1960-06-15; Total score [AUDIT-C] 1 on 1960-10-13 [S]

Strengths and supports: Supports: a close friend and her editor; she shares health news with very few people [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left breast, upper outer quadrant at 2 o'clock, 2.4 cm on imaging; core biopsy grade 2, estrogen and progesterone receptor positive, HER2 negative, Ki-67 22 percent; clinical stage T2 N0 (cT2 cN0 M0); synthetic modern counterpart of the documented 1894 breast cancer, which was not disclosed to heractiveconfirmed C50.412S — Synthetic tumor details, stage, and treatment; the breast lumps, the 1960 operation, and the nondisclosure are documented (D), but no tumor details from her lifetime are used.
Estrogen receptor positive status of the breast cancer (ER 95 percent, PR 80 percent)activeconfirmed Z17.0S — Synthetic receptor result; no receptor status from her lifetime is known.
New firm lump in the upper outer quadrant of the left breast, found two weeks ago; clinically suspicious; diagnostic imaging and biopsy bookedresolvedconfirmed N63.21S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the lumps in the left breast in early 1960 are documented (D).
Duodenal ulcer found at endoscopy seven weeks ago, with Helicobacter pylori on biopsy; treated with 14 days of bismuth quadruple therapy and completing eight weeks of omeprazole; test of cure plannedresolvedconfirmed K26.9S — Synthetic modern ulcer; it echoes the ulcer among her documented illnesses, which the sources do not date.
Primary osteoarthritis of both knees, mild, with stiffness after long walks on the shoreactiveconfirmed M17.0S — Synthetic condition; it is not linked to the documented word arthritis, which she may have used to keep her cancer private.
Metastatic carcinoma in two of three left axillary sentinel lymph nodes (macrometastases, no extranodal extension); pathologic stage pT2 pN1a(sn) M0, anatomic stage IIB; recurrence score 17activeconfirmed C77.3S — Synthetic surgical pathology; spread to lymph nodes is documented later in her life, but no pathology from her lifetime is used.
Long-term use of letrozole as adjuvant endocrine therapy, with ribociclib for three yearsactiveconfirmed Z79.811S — Synthetic treatment status.
Low bone mass (osteopenia) on baseline DXA before letrozole: lumbar spine T-score -1.8, femoral neck -1.3; 10-year major osteoporotic fracture risk about 7 percent (FRAX); vitamin D insufficiencyactiveconfirmed M85.80S — Synthetic finding on the baseline DXA the protocol requires for an aromatase inhibitor.
Acute viral rhinosinusitis for five days while on ribociclib, with expected grade 2 neutropenia (absolute neutrophil count 1.2) and no fever; resolved with saline irrigationresolvedconfirmed J01.90S — Synthetic common illness; it echoes the sinus infection among her documented illnesses, which the sources do not date, and is not linked to that claim.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1960-03-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
1960-03-09Hemoglobin [Mass/volume] in Blood12.3g/dL12-15.5 g/dLNormalS
1960-03-09Leukocytes [#/volume] in Blood by Automated count6.410*3/uL4-11 10*3/uLNormalS
1960-03-09Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
1960-03-09Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
1960-03-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L<=33 U/LNormalS
1960-03-09Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma20U/L<=32 U/LNormalS
1960-03-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1960-03-18Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]8{score}S
1960-04-20Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
1960-04-20Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]5{score}S
1960-06-15Hemoglobin [Mass/volume] in Blood12.8g/dL12-15.5 g/dLNormalS
1960-06-15Leukocytes [#/volume] in Blood by Automated count5.910*3/uL4-11 10*3/uLNormalS
1960-06-15Neutrophils [#/volume] in Blood by Automated count3.410*3/uL1.8-7.7 10*3/uLNormalS
1960-06-15Platelets [#/volume] in Blood by Automated count24010*3/uL150-400 10*3/uLNormalS
1960-06-15Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
1960-06-15Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1955)/1.73 sq M87mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1960-06-15Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma20U/L<=33 U/LNormalS
1960-06-15Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L<=32 U/LNormalS
1960-06-15Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL<=1.2 mg/dLNormalS
1960-06-15Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
1960-06-15Magnesium [Mass/volume] in Serum or Plasma2.1mg/dL1.7-2.4 mg/dLNormalS
1960-06-15Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
1960-06-15Cholesterol [Mass/volume] in Serum or Plasma208mg/dL<=199 mg/dLHighS
1960-06-15Cholesterol in HDL [Mass/volume] in Serum or Plasma62mg/dL>=50 mg/dLNormalS
1960-06-15Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation124mg/dL<=99 mg/dLHighS
1960-06-15Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
1960-06-1525-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma22ng/mL30-100 ng/mLLowS
1960-06-15Q-T interval corrected418msRibociclib is started only when QTcF is below 450 msNormalS
1960-06-15DXA Lumbar spine [T-score] Bone density-1.8{T-score}>=-1LowS
1960-06-15DXA Femur [T-score] Bone density-1.3{T-score}>=-1LowS
1960-09-08Hemoglobin [Mass/volume] in Blood12.5g/dL12-15.5 g/dLNormalS
1960-09-08Leukocytes [#/volume] in Blood by Automated count3.410*3/uL4-11 10*3/uLLowS
1960-09-08Neutrophils [#/volume] in Blood by Automated count1.610*3/uL1.8-7.7 10*3/uLLowS
1960-09-08Platelets [#/volume] in Blood by Automated count19210*3/uL150-400 10*3/uLNormalS
1960-09-08Creatinine [Mass/volume] in Serum or Plasma0.8mg/dL0.5-1.1 mg/dLNormalS
1960-09-08Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma31U/L<=33 U/LNormalS
1960-09-08Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma29U/L<=32 U/LNormalS
1960-09-08Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL<=1.2 mg/dLNormalS
1960-09-08Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
1960-09-08Magnesium [Mass/volume] in Serum or Plasma2mg/dL1.7-2.4 mg/dLNormalS
1960-09-08Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
1960-09-0825-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma34ng/mL30-100 ng/mLNormalS
1960-09-08Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1960-07-20Leukocytes [#/volume] in Blood by Automated count2.910*3/uL4-11 10*3/uLLowS
1960-07-20Neutrophils [#/volume] in Blood by Automated count1.210*3/uL1.8-7.7 10*3/uLLowS
1960-07-20Hemoglobin [Mass/volume] in Blood12.2g/dL12-15.5 g/dLNormalS
1960-07-20Platelets [#/volume] in Blood by Automated count16810*3/uL150-400 10*3/uLNormalS
1960-10-13Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1960-10-13Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1960-03-09Body height163cmS
1960-03-09Body weight59.4kgS
1960-03-09Body mass index (BMI) [Ratio]22.4kg/m2S
1960-03-09Systolic blood pressure124mm[Hg]S
1960-03-09Diastolic blood pressure78mm[Hg]S
1960-03-09Heart rate76/minS
1960-03-09Respiratory rate14/minS
1960-03-09Body temperature36.7CelS
1960-03-09Oxygen saturation in Arterial blood by Pulse oximetry98%S
1960-03-18Body height163cmS
1960-03-18Body weight59kgS
1960-03-18Body mass index (BMI) [Ratio]22.2kg/m2S
1960-03-18Systolic blood pressure130mm[Hg]S
1960-03-18Diastolic blood pressure80mm[Hg]S
1960-03-18Heart rate84/minS
1960-03-18Respiratory rate16/minS
1960-03-18Body temperature36.6CelS
1960-03-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
1960-04-20Body height163cmS
1960-04-20Body weight58.6kgS
1960-04-20Body mass index (BMI) [Ratio]22.1kg/m2S
1960-04-20Systolic blood pressure122mm[Hg]S
1960-04-20Diastolic blood pressure76mm[Hg]S
1960-04-20Heart rate74/minS
1960-04-20Respiratory rate14/minS
1960-04-20Body temperature36.7CelS
1960-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
1960-06-15Body height163cmS
1960-06-15Body weight58.9kgS
1960-06-15Body mass index (BMI) [Ratio]22.2kg/m2S
1960-06-15Systolic blood pressure120mm[Hg]S
1960-06-15Diastolic blood pressure76mm[Hg]S
1960-06-15Heart rate70/minS
1960-06-15Respiratory rate14/minS
1960-06-15Body temperature36.6CelS
1960-06-15Oxygen saturation in Arterial blood by Pulse oximetry99%S
1960-09-08Body height163cmS
1960-09-08Body weight59.6kgS
1960-09-08Body mass index (BMI) [Ratio]22.4kg/m2S
1960-09-08Systolic blood pressure118mm[Hg]S
1960-09-08Diastolic blood pressure74mm[Hg]S
1960-09-08Heart rate72/minS
1960-09-08Respiratory rate14/minS
1960-09-08Body temperature36.6CelS
1960-09-08Oxygen saturation in Arterial blood by Pulse oximetry99%S
1960-07-20Body height163cmS
1960-07-20Body weight59.2kgS
1960-07-20Body mass index (BMI) [Ratio]22.3kg/m2S
1960-07-20Systolic blood pressure118mm[Hg]S
1960-07-20Diastolic blood pressure74mm[Hg]S
1960-07-20Heart rate82/minS
1960-07-20Respiratory rate16/minS
1960-07-20Body temperature37.3CelS
1960-07-20Oxygen saturation in Arterial blood by Pulse oximetry98%S
1960-10-13Body height163cmS
1960-10-13Body weight59.8kgS
1960-10-13Body mass index (BMI) [Ratio]22.5kg/m2S
1960-10-13Systolic blood pressure116mm[Hg]S
1960-10-13Diastolic blood pressure74mm[Hg]S
1960-10-13Heart rate70/minS
1960-10-13Respiratory rate14/minS
1960-10-13Body temperature36.6CelS
1960-10-13Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
1960-03-09Primary care visit for a new left breast lump; follow-up of a recently treated duodenal ulcerfinishedS
1960-03-18Disclosure of the biopsy diagnosis of breast cancer and shared decision-making, with the breast surgical oncology consultation the same dayfinishedS
1960-04-20Review two weeks after lumpectomy and sentinel node biopsy: full disclosure of the pathology and the adjuvant treatment decisionfinishedS
1960-06-15Start of letrozole, ribociclib, and zoledronic acid after radiationfinishedS
1960-09-08Monitoring visit at the start of the fourth ribociclib cyclefinishedS
1960-07-20Same-day sick visit for sinus symptoms on ribociclibfinishedS
1960-10-13Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Diagnostic mammography and ultrasound of the left breast and axilla this week, then image-guided core biopsy with ER, PR, HER2, and Ki-67 testingcompletedGL-NCCN-BREAST-2025, GL-CMID-2026S
Breast surgical oncology consultation once the biopsy result is available, to discuss surgical options and axillary staging with hercompletedGL-NCCN-BREAST-2025S
Disclosure and shared decision-making: ask what she wants to know, give each result in person and in plain words with a written copy, check understanding by teach-back, and make every decision with her; share her health information only with the people she namescompletedGL-AMA-2.1.3, GL-ASCO-COMM-2017S
Test of cure for Helicobacter pylori by urea breath test at least four weeks after antibiotics and two weeks after stopping omeprazolecompletedGL-ACG-HP-2024S
Knee osteoarthritis: walking and strengthening exercise, acetaminophen as needed, no nonsteroidal anti-inflammatory drugs after her ulcercompletedGL-ACR-OA-2019S
Germline multigene panel testing with genetic counseling before surgery, as recommended for breast cancer diagnosed at 65 or youngercompletedGL-ASCO-SSO-GERM-2024, GL-NCCN-BREAST-2025S
Left breast-conserving surgery (lumpectomy) with sentinel lymph node biopsy, her choice after mastectomy was also explained; no axillary dissection if one or two sentinel nodes are involved and she has whole-breast radiationcompletedGL-NCCN-BREAST-2025, GL-ASCO-AXILLA-2021S
Hypofractionated whole-breast and regional nodal radiation with a tumor-bed boost by the radiation oncology team, booked in the afternoons so she can write in the morningscompletedGL-NCCN-BREAST-2025S
Letrozole 2.5 mg daily for at least five years with ribociclib 400 mg on days 1 to 21 of each 28-day cycle for three years, chosen by her; no chemotherapy with a recurrence score of 17; ECG before starting and about day 14, blood counts and liver tests every two weeks for two cycles and then at the start of the next four cycles, and electrolytes at the start of the first six cycles; avoid drugs that prolong the QT intervalcompletedGL-NCCN-BREAST-2025, GL-ASCO-CDK46-2024, GL-FDA-RIBOCICLIB-2026, GL-ASCO-ENDO-2019S
Bone health: baseline DXA, dental check, then zoledronic acid 4 mg every six months for three years; vitamin D and calcium from food; weight-bearing exercise; DXA every two yearscompletedGL-ASCO-BMA-2022, GL-CMID-2026S
Survivorship care: history and examination every 3 to 6 months, a mammogram 6 to 12 months after radiation and then yearly, no routine tumor markers or body imaging; lymphedema checks, joint-pain and hot-flash review, distress screening, and a written survivorship care plancompletedGL-CMID-2026, GL-ACS-ASCO-SURV-2016, GL-ASCO-FU-2013S

Goals

GoalTargetStatusOutcomeProvenance
Receive the biopsy result in person within ten days, explained in plain words, with a copy of the report1960-03-18completedTold the diagnosis in person nine days after presentation, with the pathology report in hand; teach-back confirmed her understandingS
Make each treatment decision herself after hearing the options, benefits, and harms1960-04-20completedChose breast-conserving surgery and, after the pathology, radiation, letrozole, ribociclib, and zoledronic acidS
Complete surgery and radiation, then start endocrine therapy, within four months of diagnosis1960-06-15completedLumpectomy at three weeks, radiation completed at ten weeks, letrozole and ribociclib started at thirteen weeksS
Take adjuvant systemic therapy safely, with every safety check the drugs require done on schedule1960-12-07activeRibociclib started with QTcF 418 ms; blood counts and liver tests on schedule; the day-14 ECG was late, as recordedS
Keep writing at least four mornings a week through treatment1960-12-07activeWriting most mornings, with radiation booked in the afternoonsS

Functional Status

Mental Status